Abstract
G protein-coupled receptors (GPCRs) are the largest family of proteins involved in signal transduction across cell membranes, and represent major drug targets in all clinical areas. Oligomerization of GPCRs and its implications in drug discovery constitute an exciting area in contemporary biology. In this review, we have highlighted the role of membrane cholesterol and the actin cytoskeleton in GPCR oligomerization, using a combined approach of homo-FRET and coarse-grain molecular dynamics simulations. In the process, we have highlighted experimental and computational methods that have been successful in analyzing different facets of GPCR association. Analysis of photobleaching homo-FRET data provided novel information about the presence of receptor oligomers under varying conditions. Molecular dynamics simulations have helped to pinpoint transmembrane helices that are involved in forming the receptor dimer interface, and this appears to be dependent on membrane cholesterol content. This gives rise to the exciting and challenging possibility of age and tissue dependence of drug efficacy. We envision that GPCR oligomerization could be a game changer in future drug discovery.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Albizu L, Cottet M, Kralikova M, et al. Time-resolved FRET between GPCR ligands reveals oligomers in native tissues. Nat Chem Biol. 2010;6:587–94.
Allen JA, Roth BL. Strategies to discover unexpected targets for drugs active at G protein-coupled receptors. Annu Rev Pharmacol Toxicol. 2011;51:117–44.
Ayoub MA, Zhang Y, Kelly RS, et al. Functional interaction between angiotensin II receptor type 1 and chemokine (C-C motif) receptor 2 with implications for chronic kidney disease. PLoS One. 2015;10:e0119803.
Borst JW, Hink MA, van Hoek A, et al. Effects of refractive index and viscosity on fluorescence and anisotropy decays of enhanced cyan and yellow fluorescent proteins. J Fluoresc. 2005;15:153–60.
Bouaziz E, Emerit MB, Vodjdani G, et al. Neuronal phenotype dependency of agonist-induced internalization of the 5-HT1A serotonin receptor. J Neurosci. 2014;34:282–94.
Chakraborty H, Chattopadhyay A. Excitements and challenges in GPCR oligomerization: molecular insight from FRET. ACS Chem Neurosci. 2015;6:199–206.
Chattopadhyay A. GPCRs: lipid-dependent membrane receptors that act as drug targets. Adv Biol. 2014;2014:143023.
Clayton AHA, Chattopadhyay A. Taking care of bystander FRET in a crowded cell membrane environment. Biophys J. 2014;106:1227–8.
Cooke RM, Brown AJH, Marshall FH, et al. Structures of G protein-coupled receptors reveal new opportunities for drug discovery. Drug Discov Today. 2015;20:1355–64.
Ferré S. The GPCR heterotetramer: challenging classical pharmacology. Trends Pharmacol Sci. 2015;36:145–52.
Ganguly S, Clayton AHA, Chattopadhyay A. Organization of higher-order oligomers of the serotonin1A receptor explored utilizing homo-FRET in live cells. Biophys J. 2011;100:361–8.
Gether U. Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. Endocr Rev. 2000;21:90–113.
Gimpl G. Interaction of G protein coupled receptors and cholesterol. Chem Phys Lipids. 2016;199:61–73.
González-Maeso J, Ang RL, Yuen T, et al. Identification of a serotonin/glutamate receptor complex implicated in psychosis. Nature. 2008;452:93–7.
Guixà -González R, Javanainen M, Gómez-Soler M, et al. Membrane omega-3 fatty acids modulate the oligomerisation kinetics of adenosine A2A and dopamine D2 receptors. Sci Rep. 2016;6:19839.
Heilker R, Wolff M, Tautermann CS, et al. G-protein-coupled receptor-focused drug discovery using a target class platform approach. Drug Discov Today. 2009;14:231–40.
Heng BC, Aubel D, Fussenegger M. An overview of the diverse roles of G-protein coupled receptors (GPCRs) in the pathophysiology of various human diseases. Biotechnol Adv. 2013;31:1676–94.
Herrick-Davis K, Grinde E, Cowan A, et al. Fluorescence correlation spectroscopy analysis of serotonin, adrenergic, muscarinic, and dopamine receptor dimerization: the oligomer number puzzle. Mol Pharmacol. 2013;84:630–42.
Huang J, Chen S, Zhang JJ, et al. Crystal structure of oligomeric β1-adrenergic G protein-coupled receptors in ligand-free basal state. Nat Struct Mol Biol. 2013;20:419–25.
Insel PA, Tang C-M, Hahntow I, et al. Impact of GPCRs in clinical medicine: monogenic diseases, genetic variants and drug targets. Biochim Biophys Acta. 2007;1768:994–1005.
Jacobson KA. New paradigms in GPCR drug discovery. Biochem Pharmacol. 2015;98:541–55.
Jafurulla M, Chattopadhyay A. Membrane lipids in the function of serotonin and adrenergic receptors. Curr Med Chem. 2013;20:47–55.
Jafurulla M, Tiwari S, Chattopadhyay A. Identification of cholesterol recognition amino acid consensus (CRAC) motif in G-protein coupled receptors. Biochem Biophys Res Commun. 2011;404:569–73.
Kasai RS, Kusumi A. Single-molecule imaging revealed dynamic GPCR dimerization. Curr Opin Cell Biol. 2014;27:78–86.
Lidke DS, Nagy P, Barisas BG, et al. Imaging molecular interactions in cells by dynamic and static fluorescence anisotropy (rFLIM and emFRET). Biochem Soc Trans. 2003;31:1020–7.
Lohse MJ. Dimerization in GPCR mobility and signaling. Curr Opin Pharmacol. 2010;10:53–8.
Martin M, Dotti CG, Ledesma MD. Brain cholesterol in normal and pathological aging. Biochim Biophys Acta. 2010;1801:934–44.
Meyer BH, Segura J-M, Martinez KL, et al. FRET imaging reveals that functional neurokinin-1 receptors are monomeric and reside in membrane microdomains of live cells. Proc Natl Acad Sci U S A. 2006;103:2138–43.
Milligan G. The role of dimerisation in the cellular trafficking of G-protein-coupled receptors. Curr Opin Pharmacol. 2010;10:23–9.
Mondal S, Johnston JM, Wang H, et al. Membrane driven spatial organization of GPCRs. Sci Rep. 2013;3:2909.
Oates J, Watts A. Uncovering the intimate relationship between lipids, cholesterol and GPCR activation. Curr Opin Struct Biol. 2011;21:802–7.
Oddi S, Dainese E, Fezza F, et al. Functional characterization of putative cholesterol binding sequence (CRAC) in human type-1 cannabinoid receptor. J Neurochem. 2011;116:858–65.
Paila YD, Chattopadhyay A. The function of G-protein coupled receptors and membrane cholesterol: specific or general interaction? Glycoconj J. 2009;26:711–20.
Paila YD, Chattopadhyay A. Membrane cholesterol in the function and organization of G-protein coupled receptors. Subcell Biochem. 2010;51:439–66.
Paila YD, Kombrabail M, Krishnamoorthy G, et al. Oligomerization of the serotonin1A receptor in live cells: a time-resolved fluorescence anisotropy approach. J Phys Chem B. 2011;115:11439–47.
Paila YD, Tiwari S, Chattopadhyay A. Are specific nonannular cholesterol binding sites present in G-protein coupled receptors? Biochim Biophys Acta. 2009;1788:295–302.
Pal S, Chakraborty H, Bandari S, et al. Molecular rheology of neuronal membranes explored using a molecular rotor: implications for receptor function. Chem Phys Lipids. 2016;196:69–75.
Palczewski K. Oligomeric forms of G protein-coupled receptors (GPCRs). Trends Biochem Sci. 2010;35:595–600.
Periole X, Huber T, Marrink S-J, et al. G protein-coupled receptors self-assemble in dynamics simulations of model bilayers. J Am Chem Soc. 2007;129:10126–32.
Pierce KL, Premont RT, Lefkowitz RJ. Seven-transmembrane receptors. Nat Rev Mol Cell Biol. 2002;3:639–50.
Piston DW, Kremers G-J. Fluorescent protein FRET: the good, the bad and the ugly. Trends Biochem Sci. 2007;32:407–14.
Prasanna X, Chattopadhyay A, Sengupta D. Cholesterol modulates the dimer interface of the β 2-adrenergic receptor via cholesterol occupancy sites. Biophys J. 2014;106:1290–300.
Prasanna X, Chattopadhyay A, Sengupta D. Role of lipid-mediated effects in β2-adrenergic receptor dimerization. Adv Exp Med Biol. 2015;842:247–61.
Prasanna X, Sengupta D, Chattopadhyay A. Cholesterol-dependent conformational plasticity in GPCR dimers. Sci Rep. 2016;6:31858.
Provasi D, Boz MB, Johnston JM, et al. Preferred supramolecular organization and dimer interfaces of opioid receptors from simulated self-association. PLoS Comput Biol. 2015;11:e1004148.
Pucadyil TJ, Chattopadhyay A. Role of cholesterol in the function and organization of G-protein coupled receptors. Prog Lipid Res. 2006;45:295–333.
Pucadyil TJ, Chattopadhyay A. Cholesterol depletion induces dynamic confinement of the G-protein coupled serotonin1A receptor in the plasma membrane of living cells. Biochim Biophys Acta. 2007;1768:655–68.
Pydi SP, Jafurulla M, Wai L, et al. Cholesterol modulates bitter taste receptor function. Biochim Biophys Acta. 2016;1858:2081–7.
Rosenbaum DM, Rasmussen SGF, Kobilka BK. The structure and function of G-protein-coupled receptors. Nature. 2009;459:356–63.
Schlyer S, Horuk R. I want a new drug: G-protein-coupled receptors in drug development. Drug Discov Today. 2006;11:481–93.
Sengupta D, Chattopadhyay A. Identification of cholesterol binding sites in the serotonin1A receptor. J Phys Chem B. 2012;116:12991–6.
Sengupta D, Chattopadhyay A. Molecular dynamics simulations of GPCR-cholesterol interaction: an emerging paradigm. Biochim Biophys Acta. 2015;1848:1775–82.
Shanti K, Chattopadhyay A. A new paradigm in the functioning of G-protein-coupled receptors. Curr Sci. 2000;79:402–3.
Singh P, Saxena R, Srinivas G, et al. Cholesterol biosynthesis and homeostasis in regulation of the cell cycle. PLoS One. 2013;8:e58833.
Smiljanic K, Vanmierlo T, Djordjevic AM, et al. Aging induces tissue-specific changes in cholesterol metabolism in rat brain and liver. Lipids. 2013;48:1069–77.
Terrillon S, Bouvier M. Roles of G-protein-coupled receptor dimerization. EMBO Rep. 2004;5:30–4.
Thomsen W, Frazer J, Unett D. Functional assays for screening GPCR targets. Curr Opin Biotechnol. 2005;16:655–65.
Tramier M, Piolot T, Gautier I, et al. Homo-FRET versus hetero-FRET to probe homodimers in living cells. Methods Enzymol. 2003;360:580–97.
Varma R, Mayor S. GPI-anchored proteins are organized in submicron domains at the cell surface. Nature. 1998;394:798–801.
Woehler A, Wlodarczyk J, Ponimaskin EG. Specific oligomerization of the 5-HT1A receptor in the plasma membrane. Glycoconj J. 2009;26:749–56.
Yeagle PL. Non-covalent binding of membrane lipids to membrane proteins. Biochim Biophys Acta. 2014;1838:1548–59.
Yeow EKL, Clayton AHA. Enumeration of oligomerization states of membrane proteins in living cells by homo-FRET spectroscopy and microscopy: theory and application. Biophys J. 2007;92:3098–104.
Zhang Y, DeVries ME, Skolnick J. Structure modeling of all identified G protein-coupled receptors in the human genome. PLoS Comput Biol. 2006;2:e13.
Acknowledgments
D.S. and A.C. gratefully acknowledge the support of Ramalingaswami Fellowship from the Department of Biotechnology, and J.C. Bose Fellowship from the Department of Science and Technology, Govt. of India, respectively. G.A.K. thanks the Council of Scientific and Industrial Research (Govt. of India) for the award of a Senior Research Fellowship. A.C. is an Adjunct Professor of Tata Institute of Fundamental Research (Mumbai), RMIT University (Melbourne, Australia), Indian Institute of Technology (Kanpur), and Indian Institute of Science Education and Research (Mohali). We thank members of the Chattopadhyay laboratory for their comments and discussions, and Xavier Prasanna for help with the figures.
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Sengupta, D., Kumar, G.A., Chattopadhyay, A. (2017). Interaction of Membrane Cholesterol with GPCRs: Implications in Receptor Oligomerization. In: Herrick-Davis, K., Milligan, G., Di Giovanni, G. (eds) G-Protein-Coupled Receptor Dimers. The Receptors, vol 33. Humana Press, Cham. https://doi.org/10.1007/978-3-319-60174-8_16
Download citation
DOI: https://doi.org/10.1007/978-3-319-60174-8_16
Published:
Publisher Name: Humana Press, Cham
Print ISBN: 978-3-319-60172-4
Online ISBN: 978-3-319-60174-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)